High performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI) method for simultaneous determination of venlafaxine and its three metabolites in human plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 850, Issue 1-2, 2007, Pages 405-411

  Liu, Wen ^a   Cai, Hua lin ^a   Li, Huan de ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

HPLC MS ESI; Metabolite; Venlafaxine

Indexed keywords

HPLC-MS/ESI; THERAPEUTIC DRUG MONITORING (TDM); VENLAFAXINE;

ELECTROSPRAY IONIZATION; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLITES; PHARMACOKINETICS; PLASMA (HUMAN); SOLVENTS;

DRUG PRODUCTS;

ACETONITRILE; AMMONIUM ACETATE; DESVENLAFAXINE; DRUG METABOLITE; ESTAZOLAM; FORMIC ACID; N DESMETHYLVENLAFAXINE; N O DIDESMETHYLVENLAFAXINE; TRIFLUOROACETIC ACID; UNCLASSIFIED DRUG; VENLAFAXINE;

ARTICLE; BLOOD SAMPLING; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; EXTRACTION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXANOLS; DEPRESSION; FEMALE; HUMANS; MALE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

NEWCASTLE DISEASE VIRUS;

EID: 34247212830     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.12.019     Document Type: Article

References (15)

1. Andrews J.M., Ninan P.T., and Nemeroff C.B. Depression 4 (1996) 48
2. Hicks D.R., Wolaniuk D., Russell A., Cavanaugh N., and Kraml M. Ther. Drug Monit. 16 (1994) 100
3. Deecher D.C., Beyer C.E., Johnston G., et al. J. Pharmacol. Exp. Ther. 318 (2006) 657
4. Kelsey J.E. J. Clin. Psychopharmacol. 16 (1996) 21s
5. Hackett D., and Salinas E. Eur. Psychiatry 12 Suppl. 4 (1997) 301s
6. Fogelman S.M., Schmider J., Venkatakrishnan K., Von Moltke L.L., Harmatz J.S., Shader R.I., and Greenblatt D.J. Neuropsychopharmacology 20 (1999) 480
7. Long C., Crifasi J., Maginn D., Graham M., and Teas S. J. Anal. Toxicol. 21 (1997) 166
8. Paterson S., Cordero R., and Burlinson S. J. Chromatogr. B 813 (2004) 323
9. Bhatt J., Jangid A., Venkatesh G., Subbaiah G., and Singh S. J. Chromatogr. B Analyt. Technal. Biomed. Life Sci. 829 (2005) 75
10. Clement E.M., Odontiadis J., and Franklin M. J. Chromatogr. B Biomed. Sci. Appl. 705 (1998) 303
11. Waschqler R., Moll W., Koniq P., and Conca A. Int. J. Clin. Pharmacol. Ther. 42 (2004) 724
12. Matoga M., Pehourcq F., Titier K., Dumora F., and Jarry C. J. Chromatogr. B 760 (2001) 213
13. Duverneuil C., de la Grandmaison G.L., de Mazan Court P., and Alvarez J.C. Ther. Drug Monit. 5 (2003) 565
14. Reis M., Lundmark J., Bjork H., and Bengtsson F. Ther. Drug Monit. 24 (2002) 545
15. Veefkind Adrian H., Judith H.P.M., and Erick H. Ther. Drug Monit. 22 (2000) 202